Literature DB >> 23221168

HCV superinfection and reinfection.

Jason T Blackard1.   

Abstract

The majority of acute HCV infections progress to chronicity, implying that the immune response is unable to clear virus in most instances. Reinfection with a second strain of HCV after clearance of an initial infection has been reported in several recent studies. Moreover, individuals with HCV infection may be at risk of HCV superinfection with a second strain of HCV even after the establishment of persistent infection and the development of an immunological response to the initial virus. In vivo and in vitro data regarding HCV reinfection and superinfection, including the clinical consequences of these phenomena and the impact they have on vaccines require consideration in future studies.

Entities:  

Mesh:

Year:  2012        PMID: 23221168     DOI: 10.3851/IMP2460

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  8 in total

Review 1.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

2.  Antigenic Variation in Bacterial Pathogens.

Authors:  Guy H Palmer; Troy Bankhead; H Steven Seifert
Journal:  Microbiol Spectr       Date:  2016-02

3.  Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs.

Authors:  Lauren L Knight; Katherine Wagner; Yuridia Leyva; Veronica R Bruce; Kirsten A M White; Yvonne S Talamantes; Brittany Price; Kimberly Page; Martha L Carvour
Journal:  Health Promot Pract       Date:  2018-09-18

4.  Association of Anaplasma marginale strain superinfection with infection prevalence within tropical regions.

Authors:  Elizabeth J Castañeda-Ortiz; Massaro W Ueti; Minerva Camacho-Nuez; Juan J Mosqueda; Michelle R Mousel; Wendell C Johnson; Guy H Palmer
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

5.  Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen.

Authors:  Ayman Ahmed Sakr; Jasmine M Hanifi; Ming Valerie Lin
Journal:  ACG Case Rep J       Date:  2017-02-01

6.  A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015.

Authors:  Sumathi Ramachandran; Hong Thai; Joseph C Forbi; Romeo Regi Galang; Zoya Dimitrova; Guo-Liang Xia; Yulin Lin; Lili T Punkova; Pamela R Pontones; Jessica Gentry; Sara J Blosser; Judith Lovchik; William M Switzer; Eyasu Teshale; Philip Peters; John Ward; Yury Khudyakov
Journal:  EBioMedicine       Date:  2018-11-15       Impact factor: 8.143

7.  Utilization of HCV Viremic Kidneys with Genotyping/Subtyping-Free Sofosbuvir/Velpatasvir Treatment Strategy: Experience from China.

Authors:  Hedong Zhang; Qiuhao Liu; Shanbiao Hu; Mingda Zhong; Fenghua Peng; Yong Guo; Chunhua Fang; Manhua Nie; Liang Tan; Helong Dai; Xubiao Xie; Longkai Peng; Gongbin Lan
Journal:  Biomed Res Int       Date:  2022-07-30       Impact factor: 3.246

8.  Molecular evolution in court: analysis of a large hepatitis C virus outbreak from an evolving source.

Authors:  Fernando González-Candelas; María Alma Bracho; Borys Wróbel; Andrés Moya
Journal:  BMC Biol       Date:  2013-07-19       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.